Objective: To provide physicians and allied health care professionals with guidelines for the nonpharmacologic management of migraine in clinical practice. Options: The full range and quality of nonpharmacologic therapies available for the management of migraine. Outcomes: Improvement in the nonpharmacologic management of migraine. Evidence and values: The creation of the guidelines followed a needs assessment by members of the Canadian Headache Society and included a statement of objectives; development of guidelines by multidisciplinary working groups using information from literature reviews and other resources; comparison of alternative clinical pathways and description of how published data were analysed; definition of the level of evidence for data in each case; evaluation and revision of the guidelines at a consensus conference held in Ottawa on Oct. 27-29, 1995; redrafting and insertion of tables showing key variables and data from various studies and tables of data with recommendations; and reassessment by all conference participants. Benefits, harms and costs: Augmentation of the use of nonpharmacologic therapies for the acute and prophylactic management of migraine is likely to lead to substantial benefits in both human and economic terms. Recommendations: Both the avoidance of migraine trigger factors and the use of nonpharmacologic therapies have a part to play in overall migraine management. Validation: The guidelines are based on consensus of Canadian experts in neurology, emergency medicine, psychiatry, psychology and family medicine, and consumers. Previous guidelines did not exist. Field testing of the guidelines is in progress. Sponsors: Support for the consensus conference was provided by an unrestricted educational grant from Glaxo Wellcome Inc. Editorial coordination was provided by Medical Education Programs Canada Inc.
|Original language||English (US)|
|Number of pages||8|
|State||Published - Jul 14 1998|
ASJC Scopus subject areas